Who is speaking

Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Charlotte Tighe at c.tighe@oxfordglobal.co.uk

2014 Speakers

  • Caroline Barelle
    Research Director VNAR Development, University of Aberdeen
  • Andreas Baumann
    Director, Bayer Healthcare
  • Simon Brack
    Director Discovery Research, Covagen
  • Steven Coats
    Senior Director R&D, MedImmune
  • Orla Cunningham
    Associate Director, Global Biotherapeutic Technologies, Pfizer
  • Lolke De Haan
    Director of Toxicology, MedImmune
  • Gerhardus de Jong
    Professor, Utrecht University
  • John Delaney
    Executive Director, Amgen Research, Biologic Discovery, Amgen Inc.
  • Claire Dobson
    Associate Director, Antibody Discovery & Protein Engineering, MedImmune
  • Bryan Edwards
    Head of In Vitro Platforms, Crescendo Biologics
  • Patrick Garidel
    Head of Biopharmaceutical Basic Development, Boehringer Ingelheim
  • Ellie Guardino
    Global Clinical and Development Team Leader, T-DM1; Group Medical Director, Product Development Oncology, Genentech
  • Rene Hoet
    Head Antibody Lead Discovery, Bayer
  • William Lambert
    Fellow and Head, Innovative Drug Delivery Group, MedImmune
  • Alastair Lawson
    VP Structural Biology, UCB
  • Vivian Lindo
    Associate Director Product Characterisation, MedImmune
  • Vincent Ling
    Director of New Frontier Science, Takeda
  • Kevin Lumb
    Director, Screening and Protein Sciences, Merck Research Laboratories
  • Lorenz Mayr
    Vice President, AstraZeneca
  • John McCafferty
    CEO, Iontas Ltd
  • Kendall Morrison
    Director of Protein Technologies, Agensys
  • Arthur Oubrie
    CSO, Lead Pharma
  • Karyn O’Neil
    Senior Director, Janssen R&D
  • Paul Parren
    Senior Vice President and Scientific Director, Genmab
  • Bernardo Perez-Ramirez
    Senior Scientific Director, Genzyme Corporation (Sanofi)
  • Yves Poitevin
    Head of Antibody Production, NovImmune
  • Nathan Robertson
    Senior Scientist, Heptares Therapeutics
  • Janet Sim
    Senior Research Investigator I, Novartis
  • Arne Skerra
    Professor, TU Muenchen, CEO & Co-Founder, XL Protein
  • Anke Steinmetz
    Senior Researcher, Sanofi Aventis
  • Joey Studts
    Director Protein Science, Boehringer Ingelheim
  • Annelise Vuidepot
    Head of Protein Science, Immunocore
  • Trevor Wilkinson
    Associate Director, Protein Sciences, Lead Generation, Department of Antibody Discovery and Protein Engineering, Medimmune
  • Ahmed Yasin
    Head Formulation & Delivery Research, GSK
  • Katherine Young
    Principal Scientist, Merck Research Laboratories/MSD
proteins2013_testimonial4proteins2013_testimonial2proteins2013_testimonial5proteins2013_testimonial1proteins2013_testimonial6proteins2013_testimonial7proteins2013_testimonial8